Clinical Trial Update: V-Flex Plus PTX Drug Eluting Coronary Stent [NA]

View source ↗

Summary

A clinical trial evaluating the V-Flex Plus PTX drug-eluting coronary stent sponsored by Cook Group Incorporated has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• V-Flex Plus PTX Drug Eluting Coronary Stent

Snippet

Sponsor: Cook Group Incorporated | Conditions: Coronary Artery Disease | NA | Status: COMPLETED